Ulcerative colitis
Conditions
Interventions
Experimental Group:For patients treated with mesalazine enema, a precise enema optimization system was adopted after routine guidance
Sponsors
Beijing Friendship Hospital ,Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Aged 18 years or older, meeting the diagnostic criteria for the active phase of ulcerative colitis as defined by the "Chinese Consensus on Diagnosis and Treatment of Inflammatory Bowel Disease (2018, Beijing)," with a disease duration of at least one month; 2.Currently undergoing mesalazine enema treatment; 3.Current mesalazine enema therapy.
Exclusion criteria
Exclusion criteria: 1.Patients unable to cooperate with the treatment; 2.Pregnant or breastfeeding patients; 3.Patients with severe underlying comorbidities, such as cardiovascular, cerebrovascular, hepatic, pulmonary, or renal diseases; 4.Patients with concurrent intestinal infections, intestinal obstruction, intestinal bleeding, or fulminant ulcerative colitis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Enema retention time;Lichtiger Clinical Activity Index score;IBD Quality of Life Score; | — |
Countries
China
Contacts
Public ContactSun Yue
Beijing Friendship Hospital ,Capital Medical University
Outcome results
None listed